Usana Health Sciences/$USNA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Usana Health Sciences
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
Ticker
$USNA
Sector
Primary listing
NYSE
Employees
1,570
Headquarters
Website
USNA Metrics
BasicAdvanced
$352m
32.84
$0.58
0.70
-
Price and volume
Market cap
$352m
Beta
0.7
52-week high
$38.32
52-week low
$16.60
Average daily volume
117k
Financial strength
Current ratio
2.243
Quick ratio
1.303
Long term debt to equity
2.099
Total debt to equity
5.451
Interest coverage (TTM)
60.41%
Profitability
EBITDA (TTM)
83.424
Gross margin (TTM)
78.29%
Net profit margin (TTM)
1.16%
Operating margin (TTM)
5.50%
Effective tax rate (TTM)
72.36%
Revenue per employee (TTM)
$590,000
Management effectiveness
Return on assets (TTM)
4.26%
Return on equity (TTM)
1.96%
Valuation
Price to earnings (TTM)
32.845
Price to revenue (TTM)
0.382
Price to book
0.65
Price to tangible book (TTM)
1.33
Price to free cash flow (TTM)
41.414
Free cash flow yield (TTM)
2.41%
Free cash flow per share (TTM)
0.46
Growth
Revenue change (TTM)
8.28%
Earnings per share change (TTM)
-73.55%
3-year revenue growth (CAGR)
-2.51%
10-year revenue growth (CAGR)
0.07%
3-year earnings per share growth (CAGR)
-45.56%
10-year earnings per share growth (CAGR)
-16.66%
What the Analysts think about USNA
Analyst ratings (Buy, Hold, Sell) for Usana Health Sciences stock.
USNA Financial Performance
Revenues and expenses
USNA Earnings Performance
Company profitability
USNA News
AllArticlesVideos
USANA Schedules First Quarter 2026 Earnings Release and Conference Call
Business Wire·2 weeks ago
USANA Health Sciences to Participate in Upcoming Investor Conferences
Business Wire·2 months ago
USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Usana Health Sciences stock?
Usana Health Sciences (USNA) has a market cap of $352M as of May 01, 2026.
What is the P/E ratio for Usana Health Sciences stock?
The price to earnings (P/E) ratio for Usana Health Sciences (USNA) stock is 32.84 as of May 01, 2026.
Does Usana Health Sciences stock pay dividends?
No, Usana Health Sciences (USNA) stock does not pay dividends to its shareholders as of May 01, 2026.
When is the next Usana Health Sciences dividend payment date?
Usana Health Sciences (USNA) stock does not pay dividends to its shareholders.
What is the beta indicator for Usana Health Sciences?
Usana Health Sciences (USNA) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.